<DOC>
	<DOCNO>NCT01847222</DOCNO>
	<brief_summary>Safety assessment SANGUINATE™ Healthy Volunteers .</brief_summary>
	<brief_title>An Assessment Safety Pharmacokinetics Ascending Doses SANGUINATE™ Healthy Volunteers .</brief_title>
	<detailed_description>Safety Pharmacokinetic assessment ascend dos SANGUINATE™ Healthy Volunteers .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male Volunteers ; Age ≥18 year ≤45 year ; BMI ≥20 ≤30 kg/m² No clinically significant screen observation Female volunteer ; Any history significant cardiac , renal , neurologic , metabolic , pulmonary , gastrointestinal , chronic hepatic disease disease judgment Investigator would interfere study confound result ; History allergy major allergic reaction consider clinically significant Investigator ; Any screen assessment determine clinically significant Investigator ; Donate blood within 60 day screen otherwise experience blood loss &gt; 250 mL within period ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>